Skip to content
Disclosery

University of Wisconsin Foundation

Follow

13F filer, CIK 1697228, MADISON, WI

University of Wisconsin Foundation reported $118,931,477 across 8 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001697228-26-000002

Period
2025-12-31
Reported value
$119M
Holdings
8
Top 10 weight
100%
New
2
Sold out
3

Largest buys vs the previous quarter

SecurityShares changeApprox. value
PCVXnew+247,000$11.4M
AAPLadded+26,040$7.08M
NVDAadded+34,040$6.35M
MSFTadded+12,998$6.29M
JANXnew+362,000$5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
AKROexited-328,504-$15.6M
RNAMexited-289,201-$12.6M
MDGLexited-13,007-$5.97M
DYNreduced-101,000-$1.98M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001697228-26-000002, largest first. % of portfolio is the value over $118,931,477, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NUNU HLDGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,431,951 shares; 2024Q4: 1,431,951 shares; 2025Q1: 1,431,951 shares; 2025Q2: 1,431,951 shares; 2025Q3: 1,431,951 shares; 2025Q4: 1,431,951 shares 1,431,951$24M20.16%0Timeline
PDCCPEARL DIVER CREDIT COMPANY IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,459,221 shares; 2024Q4: 1,459,221 shares; 2025Q1: 1,459,221 shares; 2025Q2: 1,459,021 shares; 2025Q3: 1,459,021 shares; 2025Q4: 1,459,021 shares 1,459,021$20.3M17.09%0Timeline
AAPLAPPLE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 39,402 shares; 2025Q4: 65,442 shares 65,442$17.8M14.96%+26,040Timeline
NVDANVIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 55,066 shares; 2025Q4: 89,106 shares 89,106$16.6M13.97%+34,040Timeline
MSFTMICROSOFT CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 19,431 shares; 2025Q4: 32,429 shares 32,429$15.7M13.19%+12,998Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 247,000 shares 247,000$11.4M9.58%newTimeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 517,750 shares; 2025Q4: 416,750 shares 416,750$8.15M6.85%-101,000Timeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 362,000 shares 362,000$5M4.2%newTimeline

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
AKROAKERO THERAPEUTICS INC328,504$15.6Mshares
RNAMAVIDITY BIOSCIENCES INC289,201$12.6Mshares
MDGLMADRIGAL PHARMACEUTICALS INC13,007$5.97Mshares

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001697228-26-000002 base2026-02-13acceptance time not in the bulk data set